In mice, Nampt expression in the hippocampus decreased with aging, and treatment of FK866 lowered the intracellular NAD+ level in rat neuronal cells and induced cell death, which suggested that Nampt might regulate age-related brain diseases [34]. Here, NAMPT is linked to age.